Loading...
Header Logo
Keywords
Last Name
Institution

Dr Roma Chilengi

TitleChief Scientific Officer
InstitutionCentre for Infectious Diseases Research in Zambia
AddressZambia
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    I am a Zambian Physician, epidemiologist and vaccinologist currently employed as Chief Scientific Officer at the Centre for Infectious Disease Research in Zambia (CIDRZ). In my current role, I oversee all research programs, do lead several research studies as well as health systems strengthening programmes. Having primarily worked on vaccine preventable infectious disease research in for the past 18 years, my interests have been shifted towards non-communicable diseases in the last few years. I have ongoing research in enteric disease and working on several vaccine studies including rotavirus, ETEC, and Shigella. I held an R01 IRIDA grant 1R01AI099605, which evaluated potential causes of rotavirus vaccine failure in Zambian infants, and presently hold a senior Fellowship Award from the European Developing Countries Clinical Trials Partnership (EDCTP) studying rotavirus vaccine immunogenicity.

    My research career has spanned roles as study physician on clinical studies in Zambia while at Tropical Diseases Research Centre; as sponsor based central study manager for malaria vaccine trials while at the African Malaria Network Trust in Tanzania; and as head of clinical trials facility at the University of Oxford/KEMRI-Wellcome Trust Programme in Kenya. In the course of this career, I have gained a lot of experience as a clinical investigator as well as program manager for numerous studies in Africa and have also competed for and managed various research grants.
    I have an adjunct faculty position as Assistant Professor, University of North Carolina as well as honorary lecturer appointment at the University of Zambia, School of Public Health.


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hector J, Vinikoor M, Chilengi R, Ehmer J, Egger M, Wandeler G. No Impact of Hepatitis B Virus Infection on Early Mortality Among Human Immunodeficiency Virus-Infected Patients in Southern Africa. Clin Infect Dis. 2018 09 28; 67(8):1310-1311. PMID: 29912371.
      View in: PubMed
    2. Mwanza-Lisulo M, Chomba MS, Chama M, Besa EC, Funjika E, Zyambo K, Banda R, Imikendu M, Sianongo S, Hancock REW, Lee A, Chilengi R, Stagg AJ, Namangala B, Kelly PM. Retinoic acid elicits a coordinated expression of gut homing markers on T lymphocytes of Zambian men receiving oral Vivotif, but not Rotarix, Dukoral or OPVERO vaccines. Vaccine. 2018 06 27; 36(28):4134-4141. PMID: 29801999.
      View in: PubMed
    3. Funduluka P, Bosomprah S, Chilengi R, Mugode RH, Bwembya PA, Mudenda B. Marketing of breast-milk substitutes in Zambia: evaluation of compliance to the international regulatory code. J Public Health (Oxf). 2018 03 01; 40(1):e1-e7. PMID: 28369474.
      View in: PubMed
    4. Mwila-Kazimbaya K, Garcia MP, Bosomprah S, Laban NM, Chisenga CC, Permar SR, Simuyandi M, Munsaka S, Chilengi R. Effect of innate antiviral glycoproteins in breast milk on seroconversion to rotavirus vaccine (Rotarix) in children in Lusaka, Zambia. PLoS One. 2017; 12(12):e0189351. PMID: 29284036.
      View in: PubMed
    5. Mwape I, Bosomprah S, Mwaba J, Mwila-Kazimbaya K, Laban NM, Chisenga CC, Sijumbila G, Simuyandi M, Chilengi R. Immunogenicity of rotavirus vaccine (RotarixTM) in infants with environmental enteric dysfunction. PLoS One. 2017; 12(12):e0187761. PMID: 29281659.
      View in: PubMed
    6. Hedt-Gauthier BL, Chilengi R, Jackson E, Michel C, Napua M, Odhiambo J, Bawah A. Research capacity building integrated into PHIT projects: leveraging research and research funding to build national capacity. BMC Health Serv Res. 2017 12 21; 17(Suppl 3):825. PMID: 29297405.
      View in: PubMed
    7. Wagenaar BH, Hirschhorn LR, Henley C, Gremu A, Sindano N, Chilengi R. Data-driven quality improvement in low-and middle-income country health systems: lessons from seven years of implementation experience across Mozambique, Rwanda, and Zambia. BMC Health Serv Res. 2017 12 21; 17(Suppl 3):830. PMID: 29297319.
      View in: PubMed
    8. Magge H, Chilengi R, Jackson EF, Wagenaar BH, Kante AM. Tackling the hard problems: implementation experience and lessons learned in newborn health from the African Health Initiative. BMC Health Serv Res. 2017 12 21; 17(Suppl 3):829. PMID: 29297352.
      View in: PubMed
    9. Chipungu J, Bosomprah S, Zanolini A, Thimurthy H, Chilengi R, Sharma A, Holmes CB. Understanding linkage to care with HIV self-test approach in Lusaka, Zambia - A mixed method approach. PLoS One. 2017; 12(11):e0187998. PMID: 29149194.
      View in: PubMed
    10. Chisenga CC, Musukuma K, Chilengi R, Zürcher S, Munamunungu V, Siyunda A, Ojok D, Bauer S, Wandeler G, Vinikoor M. Field performance of the Determine HBsAg point-of-care test for diagnosis of hepatitis B virus co-infection among HIV patients in Zambia. J Clin Virol. 2018 01; 98:5-7. PMID: 29175231.
      View in: PubMed
    11. Greenland K, Chipungu J, Chilekwa J, Chilengi R, Curtis V. Disentangling the effects of a multiple behaviour change intervention for diarrhoea control in Zambia: a theory-based process evaluation. Global Health. 2017 Oct 17; 13(1):78. PMID: 29041941.
      View in: PubMed
    12. O'Hara GA, McNaughton AL, Maponga T, Jooste P, Ocama P, Chilengi R, Mokaya J, Liyayi MI, Wachira T, Gikungi DM, Burbridge L, O'Donnell D, Akiror CS, Sloan D, Torimiro J, Yindom LM, Walton R, Andersson M, Marsh K, Newton R, Matthews PC. Hepatitis B virus infection as a neglected tropical disease. PLoS Negl Trop Dis. 2017 10; 11(10):e0005842. PMID: 28981505.
      View in: PubMed
    13. Vinikoor MJ, Sinkala E, Chilengi R, Mulenga LB, Chi BH, Zyambo Z, Hoffmann CJ, Saag MS, Davies MA, Egger M, Wandeler G. Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia. Clin Infect Dis. 2017 May 15; 64(10):1343-1349. PMID: 28158504.
      View in: PubMed
    14. Gitaka J, Ogwang C, Ngari M, Akoo P, Olotu A, Kerubo C, Fegan G, Njuguna P, Nyakaya G, Otieno T, Mwambingu G, Awuondo K, Lowe B, Chilengi R, Berkley JA. Clinical laboratory reference values amongst children aged 4 weeks to 17 months in Kilifi, Kenya: A cross sectional observational study. PLoS One. 2017; 12(5):e0177382. PMID: 28493930.
      View in: PubMed
    15. Mwanza M, Zulu J, Topp SM, Musonda P, Mutale W, Chilengi R. Use of Lot quality assurance sampling surveys to evaluate community health worker performance in rural Zambia: a case of Luangwa district. BMC Health Serv Res. 2017 Apr 17; 17(1):279. PMID: 28416009.
      View in: PubMed
    16. Mutale W, Masoso C, Mwanza B, Chirwa C, Mwaba L, Siwale Z, Lamisa B, Musatwe D, Chilengi R. Exploring community participation in project design: application of the community conversation approach to improve maternal and newborn health in Zambia. BMC Public Health. 2017 Mar 23; 17(1):277. PMID: 28335751.
      View in: PubMed
    17. Yan LD, Chirwa C, Chi BH, Bosomprah S, Sindano N, Mwanza M, Musatwe D, Mulenga M, Chilengi R. Hypertension management in rural primary care facilities in Zambia: a mixed methods study. BMC Health Serv Res. 2017 02 03; 17(1):111. PMID: 28158981.
      View in: PubMed
    18. Howard LM, Mwape I, Siwingwa M, Simuyandi M, Guffey MB, Stringer JS, Chi BH, Edwards KM, Chilengi R. Norovirus infections in young children in Lusaka Province, Zambia: clinical characteristics and molecular epidemiology. BMC Infect Dis. 2017 01 23; 17(1):92. PMID: 28114885.
      View in: PubMed
    19. Chung NC, Bolton-Moore C, Chilengi R, Kasaro MP, Stringer JS, Chi BH. Patient engagement in HIV care and treatment in Zambia, 2004-2014. Trop Med Int Health. 2017 03; 22(3):332-339. PMID: 28102027.
      View in: PubMed
    20. Mwila K, Chilengi R, Simuyandi M, Permar SR, Becker-Dreps S. Contribution of Maternal Immunity to Decreased Rotavirus Vaccine Performance in Low- and Middle-Income Countries. Clin Vaccine Immunol. 2017 Jan; 24(1). PMID: 27847365.
      View in: PubMed
    21. Bauer S, Wa Mwanza M, Chilengi R, Holmes CB, Zyambo Z, Furrer H, Egger M, Wandeler G, Vinikoor MJ. Awareness and management of elevated blood pressure among human immunodeficiency virus-infected adults receiving antiretroviral therapy in urban Zambia: a call to action. Glob Health Action. 2017; 10(1):1359923. PMID: 28792285.
      View in: PubMed
    22. Greenland K, Chipungu J, Curtis V, Schmidt WP, Siwale Z, Mudenda M, Chilekwa J, Lewis JJ, Chilengi R. Multiple behaviour change intervention for diarrhoea control in Lusaka, Zambia: a cluster randomised trial. Lancet Glob Health. 2016 12; 4(12):e966-e977. PMID: 27855872.
      View in: PubMed
    23. Thera MA, Coulibaly D, Kone AK, Guindo AB, Traore K, Sall AH, Diarra I, Daou M, Traore IM, Tolo Y, Sissoko M, Niangaly A, Arama C, Baby M, Kouriba B, Sissoko MS, Sagara I, Toure OB, Dolo A, Diallo DA, Remarque E, Chilengi R, Noor R, Sesay S, Thomas A, Kocken CH, Faber BW, Imoukhuede EB, Leroy O, Doumbo OK. Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara. Malar J. 2016 08 30; 15(1):442. PMID: 27577237.
      View in: PubMed
    24. Vinikoor MJ, Mulenga L, Siyunda A, Musukuma K, Chilengi R, Moore CB, Chi BH, Davies MA, Egger M, Wandeler G. Association between hepatitis B co-infection and elevated liver stiffness among HIV-infected adults in Lusaka, Zambia. Trop Med Int Health. 2016 Nov; 21(11):1435-1441. PMID: 27499385.
      View in: PubMed
    25. Sirima SB, Mordmüller B, Milligan P, Ngoa UA, Kironde F, Atuguba F, Tiono AB, Issifou S, Kaddumukasa M, Bangre O, Flach C, Christiansen M, Bang P, Chilengi R, Jepsen S, Kremsner PG, Theisen M. A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children. Vaccine. 2016 08 31; 34(38):4536-4542. PMID: 27477844.
      View in: PubMed
    26. Griffiths UK, Bozzani FM, Chansa C, Kinghorn A, Kalesha-Masumbu P, Rudd C, Chilengi R, Brenzel L, Schutte C. Costs of introducing pneumococcal, rotavirus and a second dose of measles vaccine into the Zambian immunisation programme: Are expansions sustainable? Vaccine. 2016 07 29; 34(35):4213-4220. PMID: 27371102.
      View in: PubMed
    27. Bosomprah S, Beach LB, Beres LK, Newman J, Kapasa K, Rudd C, Njobvu L, Guffey B, Hubbard S, Foo K, Bolton-Moore C, Stringer J, Chilengi R. Findings from a comprehensive diarrhoea prevention and treatment programme in Lusaka, Zambia. BMC Public Health. 2016 06 06; 16:475. PMID: 27268226.
      View in: PubMed
    28. Beres LK, Tate JE, Njobvu L, Chibwe B, Rudd C, Guffey MB, Stringer JS, Parashar UD, Chilengi R. A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia. Clin Infect Dis. 2016 May 01; 62 Suppl 2:S175-82. PMID: 27059353.
      View in: PubMed
    29. Greenland K, Chipungu J, Chilengi R, Curtis V. Theory-based formative research on oral rehydration salts and zinc use in Lusaka, Zambia. BMC Public Health. 2016 Apr 12; 16:312. PMID: 27067003.
      View in: PubMed
    30. Chilengi R, Simuyandi M, Beach L, Mwila K, Becker-Dreps S, Emperador DM, Velasquez DE, Bosomprah S, Jiang B. Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants. PLoS One. 2016; 11(3):e0150100. PMID: 26974432.
      View in: PubMed
    31. Rathod SD, Timæus IM, Banda R, Thankian K, Chilengi R, Banda A, Lemba M, Stringer JS, Chi BH. Premature adult mortality in urban Zambia: a repeated population-based cross-sectional study. BMJ Open. 2016 Mar 03; 6(3):e010801. PMID: 26940113.
      View in: PubMed
    32. Wesevich A, Chipungu J, Mwale M, Bosomprah S, Chilengi R. Health Promotion Through Existing Community Structures: A Case of Churches' Roles in Promoting Rotavirus Vaccination in Rural Zambia. J Prim Care Community Health. 2016 Apr; 7(2):81-7. PMID: 26792908.
      View in: PubMed
    33. Yan LD, Chi BH, Sindano N, Bosomprah S, Stringer JS, Chilengi R. Prevalence of hypertension and its treatment among adults presenting to primary health clinics in rural Zambia: analysis of an observational database. BMC Public Health. 2015 Sep 21; 15:933. PMID: 26391985.
      View in: PubMed
    34. Peebles K, Nchimba L, Chilengi R, Bolton Moore C, Mubiana-Mbewe M, Vinikoor MJ. Pediatric HIV-HBV Coinfection in Lusaka, Zambia: Prevalence and Short-Term Treatment Outcomes. J Trop Pediatr. 2015 Dec; 61(6):464-7. PMID: 26338421.
      View in: PubMed
    35. Mutale W, Ayles H, Bond V, Chintu N, Chilengi R, Mwanamwenge MT, Taylor A, Spicer N, Balabanova D. Application of systems thinking: 12-month postintervention evaluation of a complex health system intervention in Zambia: the case of the BHOMA. J Eval Clin Pract. 2017 Apr; 23(2):439-452. PMID: 26011652.
      View in: PubMed
    36. Rudd C, Mwenda J, Chilengi R. Rotavirus landscape in Africa-Towards prevention and control: A report of the 8th African rotavirus symposium, Livingstone, Zambia. Vaccine. 2015 Jun 26; 33(29):3263-7. PMID: 25957665.
      View in: PubMed
    37. Hodgson SH, Juma E, Salim A, Magiri C, Njenga D, Molyneux S, Njuguna P, Awuondo K, Lowe B, Billingsley PF, Cole AO, Ogwang C, Osier F, Chilengi R, Hoffman SL, Draper SJ, Ogutu B, Marsh K. Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya. Malar J. 2015 Apr 28; 14:182. PMID: 25927522.
      View in: PubMed
    38. Ngari MM, Waithira N, Chilengi R, Njuguna P, Lang T, Fegan G. Experience of using an open source clinical trials data management software system in Kenya. BMC Res Notes. 2014 Nov 26; 7:845. PMID: 25424974.
      View in: PubMed
    39. Kaddumukasa M, Buwembo W, Sekikubo M, Naiwumbwe H, Namusoke F, Kiwuwa S, Oketch B, Noor R, Chilengi R, Mworozi E, Kironde F. Malariometric indices from Iganga, Uganda: baseline characterization in preparation of GMZ2 vaccine trial. BMC Res Notes. 2014 Nov 08; 7:793. PMID: 25380673.
      View in: PubMed
    40. Kimani D, Jagne YJ, Cox M, Kimani E, Bliss CM, Gitau E, Ogwang C, Afolabi MO, Bowyer G, Collins KA, Edwards N, Hodgson SH, Duncan CJ, Spencer AJ, Knight MG, Drammeh A, Anagnostou NA, Berrie E, Moyle S, Gilbert SC, Soipei P, Okebe J, Colloca S, Cortese R, Viebig NK, Roberts R, Lawrie AM, Nicosia A, Imoukhuede EB, Bejon P, Chilengi R, Bojang K, Flanagan KL, Hill AV, Urban BC, Ewer KJ. Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations. Mol Ther. 2014 Nov; 22(11):1992-2003. PMID: 24930599.
      View in: PubMed
    41. Schuttner L, Sindano N, Theis M, Zue C, Joseph J, Chilengi R, Chi BH, Stringer JS, Chintu N. A mobile phone-based, community health worker program for referral, follow-up, and service outreach in rural Zambia: outcomes and overview. Telemed J E Health. 2014 Aug; 20(8):721-8. PMID: 24926815.
      View in: PubMed
    42. Mutale W, Stringer J, Chintu N, Chilengi R, Mwanamwenge MT, Kasese N, Balabanova D, Spicer N, Lewis J, Ayles H. Application of balanced scorecard in the evaluation of a complex health system intervention: 12 months post intervention findings from the BHOMA intervention: a cluster randomised trial in Zambia. PLoS One. 2014; 9(4):e93977. PMID: 24751780.
      View in: PubMed
    43. Holmes CB, Sikazwe I, Raelly RL, Freeman BL, Wambulawae I, Silwizya G, Topp SM, Chilengi R, Henostroza G, Kapambwe S, Simbeye D, Sibajene S, Chi H, Godfrey K, Chi B, Moore CB. Managing multiple funding streams and agendas to achieve local and global health and research objectives: lessons from the field. J Acquir Immune Defic Syndr. 2014 Jan 01; 65 Suppl 1:S32-5. PMID: 24321983.
      View in: PubMed
    44. Stringer JS, Chisembele-Taylor A, Chibwesha CJ, Chi HF, Ayles H, Manda H, Mazimba W, Schuttner L, Sindano N, Williams FB, Chintu N, Chilengi R. Protocol-driven primary care and community linkages to improve population health in rural Zambia: the Better Health Outcomes through Mentoring and Assessment (BHOMA) project. BMC Health Serv Res. 2013; 13 Suppl 2:S7. PMID: 23819614.
      View in: PubMed
    45. Ogwang C, Afolabi M, Kimani D, Jagne YJ, Sheehy SH, Bliss CM, Duncan CJ, Collins KA, Garcia Knight MA, Kimani E, Anagnostou NA, Berrie E, Moyle S, Gilbert SC, Spencer AJ, Soipei P, Mueller J, Okebe J, Colloca S, Cortese R, Viebig NK, Roberts R, Gantlett K, Lawrie AM, Nicosia A, Imoukhuede EB, Bejon P, Urban BC, Flanagan KL, Ewer KJ, Chilengi R, Hill AV, Bojang K. Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults. PLoS One. 2013; 8(3):e57726. PMID: 23526949.
      View in: PubMed
    46. A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med. 2012 Dec 13; 367(24):2284-95. PMID: 23136909.
      View in: PubMed
    47. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med. 2011 11 17; 365(20):1863-75. PMID: 22007715.
      View in: PubMed
    48. Chilengi R, Juma R, Abdallah AM, Bashraheil M, Lodenyo H, Nyakundi P, Anabwani E, Salim A, Mwambingu G, Wenwa E, Jemutai J, Kipkeu C, Oyoo GO, Muchohi SN, Kokwaro G, Niehues T, Lang T, Nzila A. A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers. Malar J. 2011 Mar 16; 10:63. PMID: 21410944.
      View in: PubMed
    49. Chilengi R, Gitaka J. Is vaccine the magic bullet for malaria elimination? A reality check. Malar J. 2010 Dec 13; 9 Suppl 3:S1. PMID: 21144081.
      View in: PubMed
    50. Mordmüller B, Szywon K, Greutelaers B, Esen M, Mewono L, Treut C, Mürbeth RE, Chilengi R, Noor R, Kilama WL, Imoukhuede EB, Imbault N, Leroy O, Theisen M, Jepsen S, Milligan P, Fendel R, Kremsner PG, Issifou S. Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, Gabon. Vaccine. 2010 Sep 24; 28(41):6698-703. PMID: 20696154.
      View in: PubMed
    51. Lang TA, White NJ, Tran HT, Farrar JJ, Day NP, Fitzpatrick R, Angus BJ, Denis E, Merson L, Cheah PY, Chilengi R, Kimutai R, Marsh K. Clinical research in resource-limited settings: enhancing research capacity and working together to make trials less complicated. PLoS Negl Trop Dis. 2010 Jun 29; 4(6):e619. PMID: 20614013.
      View in: PubMed
    52. Nzila A, Chilengi R. Modulators of the efficacy and toxicity of drugs in malaria treatment. Trends Pharmacol Sci. 2010 Jun; 31(6):277-83. PMID: 20381886.
      View in: PubMed
    53. Nyika A, Chilengi R, Ishengoma D, Mtenga S, Thera MA, Sissoko MS, Lusingu J, Tiono AB, Doumbo O, Sirima SB, Lemnge M, Kilama WL. Engaging diverse communities participating in clinical trials: case examples from across Africa. Malar J. 2010 Mar 26; 9:86. PMID: 20346126.
      View in: PubMed
    54. Nzila A, Okombo J, Becker RP, Chilengi R, Lang T, Niehues T. Anticancer agents against malaria: time to revisit? Trends Parasitol. 2010 Mar; 26(3):125-9. PMID: 20056487.
      View in: PubMed
    55. Nyika A, Kilama W, Tangwa GB, Chilengi R, Tindana P. Capacity building of ethics review committees across Africa based on the results of a comprehensive needs assessment survey. Dev World Bioeth. 2009 Dec; 9(3):149-56. PMID: 20021494.
      View in: PubMed
    56. Sirima SB, Tiono AB, Ouédraogo A, Diarra A, Ouédraogo AL, Yaro JB, Ouédraogo E, Gansané A, Bougouma EC, Konaté AT, Kaboré Y, Traoré A, Chilengi R, Roma C, Soulama I, Luty AJ, Druilhe P, Cousens S, Nébié I. Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children. PLoS One. 2009 Oct 26; 4(10):e7549. PMID: 19855847.
      View in: PubMed
    57. Chilengi R. Clinical development of malaria vaccines: should earlier trials be done in malaria endemic countries? Hum Vaccin. 2009 Sep; 5(9):627-36. PMID: 19617708.
      View in: PubMed
    58. Chilengi R. An ethics perspective on responsibilities of investigators, sponsors and research participants. Acta Trop. 2009 Nov; 112 Suppl 1:S53-62. PMID: 19665980.
      View in: PubMed
    59. Lusingu JP, Gesase S, Msham S, Francis F, Lemnge M, Seth M, Sembuche S, Rutta A, Minja D, Segeja MD, Bosomprah S, Cousens S, Noor R, Chilengi R, Druilhe P. Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12-24 months. Malar J. 2009 Jul 17; 8:163. PMID: 19607731.
      View in: PubMed
    60. Kafwembe EM, Chipipa J, Njunju E, Chilengi R. The vitamin A status of Zambian children in a community of vitamin A supplementation and sugar fortification strategies as measured by the modified relative dose response (MRDR) test. Int J Vitam Nutr Res. 2009 Jan; 79(1):40-7. PMID: 19839002.
      View in: PubMed
    61. Gill CJ, Mwanakasale V, Fox MP, Chilengi R, Tembo M, Nsofwa M, Chalwe V, Mwananyanda L, Mukwamataba D, Malilwe B, Champo D, Macleod WB, Thea DM, Hamer DH. Effect of presumptive co-trimoxazole prophylaxis on pneumococcal colonization rates, seroepidemiology and antibiotic resistance in Zambian infants: a longitudinal cohort study. Bull World Health Organ. 2008 Dec; 86(12):929-38. PMID: 19142293.
      View in: PubMed
    62. Dodoo D, Aikins A, Kusi KA, Lamptey H, Remarque E, Milligan P, Bosomprah S, Chilengi R, Osei YD, Akanmori BD, Theisen M. Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children. Malar J. 2008 Jul 29; 7:142. PMID: 18664257.
      View in: PubMed
    63. Lang T, Chilengi R, Noor RA, Ogutu B, Todd JE, Kilama WL, Targett GA. Data safety and monitoring boards for African clinical trials. Trans R Soc Trop Med Hyg. 2008 Dec; 102(12):1189-94. PMID: 18644610.
      View in: PubMed
    64. Gill CJ, Mwanakasale V, Fox MP, Chilengi R, Tembo M, Nsofwa M, Chalwe V, Mwananyanda L, Mukwamataba D, Malilwe B, Champo D, Macleod WB, Thea DM, Hamer DH. Impact of human immunodeficiency virus infection on Streptococcus pneumoniae colonization and seroepidemiology among Zambian women. J Infect Dis. 2008 Apr 01; 197(7):1000-5. PMID: 18419536.
      View in: PubMed
    65. Nebie I, Diarra A, Ouedraogo A, Soulama I, Bougouma EC, Tiono AB, Konate AT, Chilengi R, Theisen M, Dodoo D, Remarque E, Bosomprah S, Milligan P, Sirima SB. Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa. Infect Immun. 2008 Feb; 76(2):759-66. PMID: 18070896.
      View in: PubMed
    66. Kilama WL, Chilengi R, Wanga CL. Towards an African-driven malaria vaccine development program: history and activities of the African Malaria Network Trust (AMANET). Am J Trop Med Hyg. 2007 Dec; 77(6 Suppl):282-8. PMID: 18165504.
      View in: PubMed
    67. Hamer DH, Mwanakasale V, Macleod WB, Chalwe V, Mukwamataba D, Champo D, Mwananyanda L, Chilengi R, Mubikayi L, Mulele CK, Mulenga M, Thea DM, Gill CJ. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women. J Infect Dis. 2007 Dec 01; 196(11):1585-94. PMID: 18008241.
      View in: PubMed
    68. Gill CJ, Macleod WB, Mwanakasale V, Chalwe V, Mwananyanda L, Champo D, Mukwamataba D, Chilengi R, Thea DM, Hamer DH. Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women. J Infect Dis. 2007 Dec 01; 196(11):1577-84. PMID: 18008240.
      View in: PubMed
    69. Van Geertruyden JP, Mulenga M, Mwananyanda L, Chalwe V, Moerman F, Chilengi R, Kasongo W, Van Overmeir C, Dujardin JC, Colebunders R, Kestens L, D'Alessandro U. HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria. J Infect Dis. 2006 Oct 01; 194(7):917-25. PMID: 16960779.
      View in: PubMed
    70. Mulenga M, VangGeertruyden JP, Mwananyanda L, Chalwe V, Moerman F, Chilengi R, Van Overmeir C, Dujardin JC, D'Alessandro U. Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults. Malar J. 2006 Aug 21; 5:73. PMID: 16923176.
      View in: PubMed
    Chilengi's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _